Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02775955 · ClinicalTrials.gov registry record · Phase 1

PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function

A Phase 1 study of Healthy, sponsored by Pharmaceutical Project Solutions.

Completed
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT02775955: Completed Phase 1 study of Healthy, sponsored by Pharmaceutical Project Solutions.

NCT02775955 is a Phase 1 study of Healthy that has completed, run by Pharmaceutical Project Solutions. The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02775955, a Phase 1 study of Healthy, has completed, sponsored by Pharmaceutical Project Solutions.

COMPLETED
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to evaluate the potential effect of renal impairment on the systemic pharmacokinetics of acute Intranasal RX0041-002. The secondary objective is to evaluate the safety and tolerability of acute Intranasal RX0041-002 in subjects with normal renal function and severe renal impairment.

Conditions Studied

Interventions

  • DRUG RX0041

Study Locations (1)

New Jersey

  • Comprehensive Clinical Researc - Berlin

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2016-02
Est. Completion 2016-10
Phase Phase 1
Pharmaceutical Project Solutions

3 total trials

What the finished NCT02775955 record still lists

NCT02775955 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which RX0041 is the first listed.

NCT02775955 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT02775955 about?

NCT02775955 is a clinical study titled "PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function". The primary objective of this study is to evaluate the potential effect of renal impairment on the systemic pharmacokinetics of acute Intranasal RX0041-002. The secondary objective is to evaluate the safety and tolerability of acute Intranasal RX0041-002 in subjects with normal renal function and se...

What is the current status of trial NCT02775955?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2016-02. Estimated completion is 2016-10.

What conditions does trial NCT02775955 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02775955?

The interventions under investigation include: RX0041 (DRUG).

Who is sponsoring clinical trial NCT02775955?

This trial is sponsored by Pharmaceutical Project Solutions, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02775955 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02775955's enrollment target sits among peer trials

24 791st of 1090 higher than 254 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02775955, the US trial registry maintained by the National Library of Medicine. NCT02775955 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.